Hair Growth Peptide Patent - Caregen Co., Ltd.
Summary
The European Patent Office granted patent EP4603502A1 to Caregen Co., Ltd. on April 1, 2026, covering a peptide composition with activities of promoting hair growth and inhibiting hair loss. The patent lists five inventors and has been designated across 31 European states including major markets. This IP grant provides Caregen with exclusive rights to their peptide technology for applications in hair care and cosmetic formulations.
What changed
The European Patent Office granted EP4603502A1 to Caregen Co., Ltd. covering a peptide composition for promoting hair growth and inhibiting hair loss. The patent, effective from April 1, 2026, names CHUNG Yong Ji, KIM Eun Mi, LEE Eung Ji, KIM Min Woong, and GIL Hana as inventors, with IPC classifications in A61Q 7/00 (hair preparations) and C07K 7/06 (peptides).
Manufacturers and developers of hair care and cosmetic products should monitor this patent grant for potential licensing requirements or freedom-to-operate implications. The patent provides Caregen with enforceable IP rights across designated European states, which may affect competitors developing similar peptide-based hair growth technologies.
What to do next
- Monitor for potential patent licensing implications
- Review product development pipelines for freedom-to-operate risks
- Assess competitive landscape for peptide-based hair growth products
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PEPTIDE HAVING ACTIVITIES OF PROMOTING HAIR GROWTH AND INHIBITING HAIR LOSS, AND USES THEREOF
Publication EP4603502A1 Kind: A1 Apr 01, 2026
Applicants
Caregen Co., Ltd.
Inventors
CHUNG, Yong Ji, KIM, Eun Mi, LEE, Eung Ji, KIM, Min Woong, GIL, Hana
IPC Classifications
A61Q 7/00 20060101AFI20260225BHEP C07K 7/06 20060101ALI20260225BHEP A61K 8/64 20060101ALI20260225BHEP A61P 17/14 20060101ALI20260225BHEP A61K 38/00 20060101ALI20260225BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.